Market Eyes LiveMarket Eyes Live

Eli Lilly & Co. (LLY) Stock Rating

MELANY's data-driven read on Eli Lilly & Co. · Pharmaceutical Preparations.

71/100
BUY
···
Live price

Eli Lilly is a drug firm focused on neuroscience, cardiometabolic disease, cancer, and immunology. Its key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic conditions; and Taltz and Olumiant for immunology.

Rating as of 2026-07-07. Live price updates in real time.

Create a free account for LLY's full trade plan

Entry zone, stop-loss, price targets, and live alerts unlock when you sign up. No card required.